Trial Profile
Clinical Trials Insight: 700030721
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2008
Price :
$35
*
At a glance
- Drugs PRX 07034 (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- Sponsors EPIX Pharmaceuticals
- 21 Feb 2008 New trial record.